Boor Kathryn Jean

Track

Insider profile

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Boor Kathryn Jean's trades of Sarepta Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
449.19
Quantity 29,490
Value US$4,922,180
Transaction date
Proposed sale
Price
297.26
Quantity 15,939
Value US$3,671,457
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-06 2024-12-05
S Sale
7,229 +40.2%
204.12
US$3,444,128 		7,229 +40.2% 204.12 US$3,444,128
2024-12-05 2024-12-05
PrS Proposed sale
29,490
449.19
US$4,922,180 		29,490 449.19 US$4,922,180
2024-03-11 2024-03-11
PrS Proposed sale
15,939
297.26
US$3,671,457 		15,939 297.26 US$3,671,457
2024-03-11 2024-03-11
S Sale
761 -9.2%
122.93
US$93,550 		761 -9.2% 122.93 US$93,550